DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n93mwn/impetigopipeline) has announced the addition of the "Impetigo-Pipeline Insights, 2016" report to their offering.
Impetigo-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Impetigo. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Impetigo.
The report also assesses the Impetigo therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
- The report provides competitive pipeline landscape of Impetigo
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Impetigo pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Impetigo and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Impetigo Overview
- Impetigo Pipeline Therapeutics
- Impetigo Therapeutics under Development by Companies
- Impetigo Filed and Phase III Products
- Comparative Analysis
- Impetigo Phase II Products
- Impetigo Phase I and IND Filed Products
- Impetigo Discovery and Pre-Clinical Stage Products
- Impetigo - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Impetigo - Discontinued Products
- Impetigo - Dormant Products
- Companies Involved in Therapeutics Development for Impetigo
For more information visit http://www.researchandmarkets.com/research/n93mwn/impetigopipeline